BVF Partners OS Ltd., 10% Owner at INFINITY PHARMACEUTICALS, INC. (INFI), bought 1,759,464 shares at $1.35 ($2.4M) on 2018-11-13, disclosed to the SEC on 2018-11-15.
Open-market purchase of $2.4M INFI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.35 | 41,454 | $56K | 2.4% |
| 2 | $1.35 | 41,454 | $56K | 2.4% |
| 3 | $1.35 | 562,754 | $760K | 32.0% |
| 4 | $1.35 | 562,754 | $760K | 32.0% |
| 5 | $1.34 | 92,960 | $125K | 5.3% |
| 6 | $1.34 | 92,960 |
| $125K |
| 5.3% |
| 7 | $1.34 | 117,290 | $157K | 6.6% |
| 8 | $1.34 | 117,290 | $157K | 6.6% |
| 9 | $1.35 | 39,074 | $53K | 2.2% |
| 10 | $1.35 | 39,074 | $53K | 2.2% |
| 11 | $1.35 | 52,400 | $71K | 3.0% |
| Total | $1.35 avg | 1,759,464 | $2.4M | 100% |
| Filing → |
| XOMA | BUY | 2020-09-23 | $1.8M | — | Filing → |
| IDYA | BUY | 2020-06-22 | $3.4M | — | Filing → |
| FPRX | BUY | 2019-12-26 | $4.2M | — | Filing → |